Altimmune said on Thursday that it plans to test its lead experimental obesity drug, pemvidutide, to potentially treat alcohol use disorder and alcohol-associated liver disease.

The Maryland-based biopharma joins Eli Lilly and Novo Nordisk in trialing a GLP-1 agonist for alcohol- and liver-related ...

Heavy alcohol use is taking an earlier toll, landing more young Americans onto transplant lists. The obesity epidemic makes ...

Validated tools for alcohol and drug misuse, such as the Alcohol Use Disorders Identification Test (AUDIT) and the Drug Abuse Screening Test (DAST), are readily available and can be administered ...

Recent research has unveiled a significant correlation between alcohol consumption patterns and sports betting behaviors, ...

This indicates that most consumers are drinking within the Health NZs low-risk drinking advice. For women this is drinking no more than two standard drinks a day, and three standard drinks a day for ...

Podcast: Is there a single explanation that accounts for all addictive behaviors, or is the reality more complex? Under the Cortex explores.

There are many resources to support parents of children with developmental disabilities, and help them to understand their ...

BACKGROUND: Research indicates that patients undergoing bariatric surgery face a six to seven times higher risk of developing alcohol use disorder (AUD) compared with the population of obese ...

Medically reviewed by Jay N. Yepuri, MD FibroScan is the brand name for transient elastography, an abdominal ultrasound that ...

In addition to the association between decreased AUDIT-C score and decreased all-cause hospital risk, researchers found that this relationship was dose dependent, with more decreases in score ...